Cargando…

Cost-effectiveness analysis of anidulafungin in the treatment of candidaemia

Detalles Bibliográficos
Autores principales:	Auzinger, G, Playford, G, Graham, C, Narula, H, Charbonneau, C, Weinstein, D, Kantecki, M, Schlamm, H, Ruhnke, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642880/ http://dx.doi.org/10.1186/cc12025

Ejemplares similares

Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis
por: Auzinger, Georg, et al.
Publicado: (2015)

Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients
por: Ruhnke, M, et al.
Publicado: (2012)

Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients
por: Ruhnke, M, et al.
Publicado: (2011)

Anidulafungin compared with fluconazole therapy in critically ill patients
por: Kett, DH, et al.
Publicado: (2010)

Pharmacokinetics of micafungin in adult patients with invasive candidiasis and candidaemia
por: Kuse, ER, et al.
Publicado: (2008)

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature
por: Kofla, G, et al.
Publicado: (2011)

Safety and Efficacy of Anidulafungin for Fungal Infection in Patients With Liver Dysfunction or Multiorgan Failure
por: Verma, Anita, et al.
Publicado: (2016)

Determinants of mortality in non-neutropenic ICU patients with candidaemia
por: Marriott, Deborah JE, et al.
Publicado: (2009)

Species distribution and antifungal susceptibility of Candida species causing candidaemia in a Thai university hospital during year 2006-2010
por: Ankkananukul, K, et al.
Publicado: (2011)

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
por: Kett, Daniel H, et al.
Publicado: (2011)

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
por: Reboli, Annette C, et al.
Publicado: (2011)

Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial
por: Pappas, Peter G, et al.
Publicado: (2023)

Biofilm profile of candidaemia isolates
por: Sheena, M.S., et al.
Publicado: (2023)

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
por: Grau, Santiago, et al.
Publicado: (2016)

Anidulafungin in the treatment of invasive fungal infections
por: Sabol, Kathryn, et al.
Publicado: (2008)

Management bundles for candidaemia: the impact of compliance on clinical outcomes
por: Takesue, Yoshio, et al.
Publicado: (2015)

Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials
por: Kullberg, Bart Jan, et al.
Publicado: (2017)

Candidaemia and cancer: patients are not all the same
por: Pasqualotto, Alessandro Comarú, et al.
Publicado: (2006)

Candidaemia in a tertiary hospital in Nigeria
por: Oladele, Rita O., et al.
Publicado: (2014)

Anidulafungin and its role in candida infections
por: Cappelletty, Diane M, et al.
Publicado: (2009)

Invasive Fungal Infections in Infants—Focus on Anidulafungin
por: Wilke, Michael H.
Publicado: (2013)

Does Weight Impact Anidulafungin Pharmacokinetics?
por: Lempers, Vincent J., et al.
Publicado: (2016)

Surgical Procedure Assessment score predicts ICU length of stay in cardiac surgical patients
por: Panzer, O, et al.
Publicado: (2006)

Safety and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children
por: Roilides, Emmanuel, et al.
Publicado: (2017)

Anidulafungin Versus Micafungin in the Treatment of Candidemia in Adult Patients
por: Suh, Jin Woong, et al.
Publicado: (2020)

Mortality in patients with early- or late-onset candidaemia
por: De Rosa, Francesco Giuseppe, et al.
Publicado: (2013)

Endocarditis Is Not Rare and Is an Independent Predictor of Mortality in Candidaemia
por: Aye, Chaw, et al.
Publicado: (2017)

Dexamethasone/methylprednisolone/tocilizumab: Candidaemia: case report
Publicado: (2021)

Pharmacokinetics of anidulafungin during albumin dialysis
por: Aguilar, Gerardo, et al.
Publicado: (2014)

Anidulafungin: Lack of efficacy: case report
Publicado: (2022)

Cost-effectiveness analysis and budgetary impact of anidulafungin treatment for patients with candidemia and other forms of invasive candidiasis in Brazil
por: Vianna, Cid Manso de Mello, et al.
Publicado: (2023)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs - review of the literature
por: Wilke, MH
Publicado: (2011)

Candidaemia in patients with haematological disorders and stem cell transplant
por: Al-Anazi, KA, et al.
Publicado: (2006)

Anidulafungin/voriconazole: Lack of efficacy: case report
Publicado: (2022)

Anidulafungin/antibacterials: Failure of response: case report
Publicado: (2022)

Anidulafungin dosing during CRRT: do not underestimate adsorption!
por: Honore, Patrick M, et al.
Publicado: (2014)

Hypercalcaemia resulting from the use of tigecycline in the treatment of multidrug-resistant Acinetobacter in patients with multiorgan failure
por: Duffy, M, et al.
Publicado: (2007)

Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study
por: Keighley, C., et al.
Publicado: (2019)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature
por: Glöckner, A
Publicado: (2011)

Cost analysis of hospital infections in a training hospital
por: Ozbek, G, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rhea90v5ifo1aa0on2co6h215i